Dr. Edith Perez, Chief Medical Officer, Bolt Biotherapeutics discusses an innovative new platform for the treatment of patients with cancer.  The Boltbody™ platform uses a combination of tumor targeting antibodies and localized stimulation of the immune system, or immune stimulating antibody conjugates, to fight cancer.  Bolt’s preclinical data show that in addition to killing the tumor, […]

An Australian medical device maker that has a cleared device to detect lymphedema struck a national purchasing agreement with the U.S. Oncology Network. The Texas-based group has more than 1,200 physicians across 470 locations, and is a subsidiary of McKesson Corporation. Lymphedema is a condition characterized by swelling in the arms and legs. It can […]

Adarza Biosystems Inc.’s Ziva platform can simultaneously detect hundreds of proteins, antibodies, or substrates from a single drop of blood, plasma or serum, providing insight into an individual’s immune response. That could be critical for both surveillance and diagnostic purposes as the nation prepares for a likely second wave of the novel coronavirus in the fall […]